Recently, four studies have confirmed that a high level of STS mRNA expression in tumours was associated with a poor prognosis in women with breast cancer (Utsumi et al, 1999; Miyoshi et al, 2003; Suzuki et al, 2003; Yoshimura et al, 2004). The gene discussed is STS; the disease is breast carcinoma.